Skip to main content
Top
Published in: Drugs & Aging 12/2011

01-12-2011 | Original Research Article

Is There a Predictive Profile for Clinical Inertia in Hypertensive Patients?

An Observational, Cross-Sectional, Multicentre Study

Authors: Prof. Dr Vicente Gil-Guillén, Domingo Orozco-Beltrán, Emilio Márquez-Contreras, Ramón Durazo-Arvizu, Richard Cooper, Salvador Pita-Fernández, Diego González-Segura, Concepción Carratalá-Munuera, José Luis Martín de Pablo, Vicente Pallarés, Salvador Pertusa-Martínez, Antonio Fernández, Josep Redón

Published in: Drugs & Aging | Issue 12/2011

Login to get access

Abstract

Background: Some studies have described a large number of hypertensive patients who are followed by a primary care physician without achieving adequate blood pressure (BP) control but whose treatment nevertheless is not intensified. It is not known whether physicians are aware of this clinical inertia and what factors are associated with this problem.
Objective: The aim of this study was to describe the factors associated with clinical inertia in hypertensive patients.
Methods: This was an observational, cross-sectional, multicentre study conducted in a network of primary care centres and hospital hypertension units in Spain. Using a consecutive sampling approach, 512 physicians selected 5077 hypertensive patients in whom they suspected poor BP control after chart review. The main variables documented were BP control and cardiovascular risk according to European Society of Hypertension guidelines, changes in treatment after visit, type of treatment, and healthcare setting. A binomial logistic regression multivariate analysis, adjusted for physician, was performed.
Results: Of the selected patients, 70.9% had poor BP control according to measurements taken in the physician’s office, and in 1499 (42.1%) of those poorly controlled patients, treatment was not intensified (clinical inertia). Factors associated with clinical inertia were as follows: being seen at a primary care centre (p<0.001), not having left ventricular hypertrophy (p<0.001) or microalbuminuria (p<0.001), taking fixed-dose (p=0.049) or free-dose (p=0.001) combination therapy, BP measured in other settings (nurse’s office, patient’s home) than the physician’s office (p=0.034) or the pharmacy (p=0.019), older age (p=0.032), and lower systolic (p<0.001) and diastolic (p<0.001) BP. Of the hypertensive patients with clinical inertia, 90.2% (95% CI 88.7, 91.7) had high cardiovascular risk.
Conclusions: Clinical inertia was associated with a profile that included older age, lack of co-morbid conditions and being seen at a primary care centre.
Literature
1.
go back to reference Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001 Nov 6; 135(9): 825–34PubMed Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001 Nov 6; 135(9): 825–34PubMed
2.
go back to reference Chobanian AV, Bakris GL, Black HR, et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP; National Heart, Lung, and Blood Institute; National High BP Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP. Hypertension 2003 Dec; 42(6): 1206–52PubMedCrossRef Chobanian AV, Bakris GL, Black HR, et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP; National Heart, Lung, and Blood Institute; National High BP Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP. Hypertension 2003 Dec; 42(6): 1206–52PubMedCrossRef
3.
go back to reference Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States [published erratum appears in Arch Intern Med 2007 Apr 9; 167 (7): 648]. Arch Intern Med 2007 Jan 22; 167(2): 141–7PubMedCrossRef Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States [published erratum appears in Arch Intern Med 2007 Apr 9; 167 (7): 648]. Arch Intern Med 2007 Jan 22; 167(2): 141–7PubMedCrossRef
4.
go back to reference Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens (Greenwich) 2000 Oct; 2(5): 324–30 Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens (Greenwich) 2000 Oct; 2(5): 324–30
5.
go back to reference Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of BP in a hypertensive population. N Engl J Med 1998 Dec 31; 339(27): 1957–63PubMedCrossRef Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of BP in a hypertensive population. N Engl J Med 1998 Dec 31; 339(27): 1957–63PubMedCrossRef
6.
go back to reference Julius S, Weber MA, Kjeldsen SE, et al. The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy. Hypertension 2006 Sep; 48(3): 385–91PubMedCrossRef Julius S, Weber MA, Kjeldsen SE, et al. The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy. Hypertension 2006 Sep; 48(3): 385–91PubMedCrossRef
7.
go back to reference Nasser SA, Lai Z, O’Connor S, et al. Does earlier attainment of BP goal translate into fewer cardiovascular events? Curr Hypertens Rep 2008 Oct; 10(5): 398–404PubMedCrossRef Nasser SA, Lai Z, O’Connor S, et al. Does earlier attainment of BP goal translate into fewer cardiovascular events? Curr Hypertens Rep 2008 Oct; 10(5): 398–404PubMedCrossRef
8.
go back to reference Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the Healthy People 2010 BP control goals. Hypertension 2006 Mar; 47(3): 345–51PubMedCrossRef Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the Healthy People 2010 BP control goals. Hypertension 2006 Mar; 47(3): 345–51PubMedCrossRef
9.
go back to reference Phillips LS, Twombly JG. It’s time to overcome clinical inertia. Ann Intern Med 2008 May 20; 148(10): 783–5PubMed Phillips LS, Twombly JG. It’s time to overcome clinical inertia. Ann Intern Med 2008 May 20; 148(10): 783–5PubMed
10.
go back to reference Roumie CL, Elasy TA, Greevy R, et al. Improving BP control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med 2006 Aug 1; 145(3): 165–75PubMed Roumie CL, Elasy TA, Greevy R, et al. Improving BP control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med 2006 Aug 1; 145(3): 165–75PubMed
11.
go back to reference Redón J, Coca A, Lázaro P, et al. Factors associated with therapeutic inertia in hypertension: validation of a predictive model. J Hypertens 2010 Aug; 28(8): 1770–7PubMedCrossRef Redón J, Coca A, Lázaro P, et al. Factors associated with therapeutic inertia in hypertension: validation of a predictive model. J Hypertens 2010 Aug; 28(8): 1770–7PubMedCrossRef
12.
go back to reference Redon J, Brunner HR, Ferri C, et al. Practical solutions to the challenges of uncontrolled hypertension: a white paper. J Hypertens Suppl 2008 Dec; 26(4): S1–14PubMedCrossRef Redon J, Brunner HR, Ferri C, et al. Practical solutions to the challenges of uncontrolled hypertension: a white paper. J Hypertens Suppl 2008 Dec; 26(4): S1–14PubMedCrossRef
13.
go back to reference Steinman MA, Fischer MA, Shlipak MG, et al. Clinician awareness of adherence to hypertension guidelines. Am J Med 2004 Nov 15; 117(10): 747–54PubMedCrossRef Steinman MA, Fischer MA, Shlipak MG, et al. Clinician awareness of adherence to hypertension guidelines. Am J Med 2004 Nov 15; 117(10): 747–54PubMedCrossRef
14.
go back to reference Oliveria SA, Lapuerta P, McCarthy BD, et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002 Feb 25; 162(4): 413–20PubMedCrossRef Oliveria SA, Lapuerta P, McCarthy BD, et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002 Feb 25; 162(4): 413–20PubMedCrossRef
15.
go back to reference Ferrari P, Hess L, Pechere-Bertschi A, et al. Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study. J Hypertens 2004 Jun; 22(6): 1221–9PubMedCrossRef Ferrari P, Hess L, Pechere-Bertschi A, et al. Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study. J Hypertens 2004 Jun; 22(6): 1221–9PubMedCrossRef
16.
go back to reference Márquez-Contreras E, Coca A, de la Figuera von Wichmann M, et al., Control-Project Researchers. Cardiovascular risk profile of uncontrolled hypertensive patients: the Control-Project study. Med Clin (Barc) 2007 Jan 27; 128(3): 86–91CrossRef Márquez-Contreras E, Coca A, de la Figuera von Wichmann M, et al., Control-Project Researchers. Cardiovascular risk profile of uncontrolled hypertensive patients: the Control-Project study. Med Clin (Barc) 2007 Jan 27; 128(3): 86–91CrossRef
17.
go back to reference Ferrari P. National Coordinators for the Reasons for not Intensifying Antihypertensive Treatment (RIAT) trial 12. Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries. J Hum Hypertens 2009 Mar; 23(3): 151–9PubMedCrossRef Ferrari P. National Coordinators for the Reasons for not Intensifying Antihypertensive Treatment (RIAT) trial 12. Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries. J Hum Hypertens 2009 Mar; 23(3): 151–9PubMedCrossRef
18.
go back to reference Bramlage P, Thoenes M, Kirch W, et al. Clinical practice and recent recommendations in hypertension management: reporting a gap in a global survey of 1259 primary care physicians in 17 countries. Curr Med Res Opin 2007 Apr; 23(4): 783–91PubMedCrossRef Bramlage P, Thoenes M, Kirch W, et al. Clinical practice and recent recommendations in hypertension management: reporting a gap in a global survey of 1259 primary care physicians in 17 countries. Curr Med Res Opin 2007 Apr; 23(4): 783–91PubMedCrossRef
19.
go back to reference Safford MM, Shewchuk R, Qu H, et al. Reasons for not intensifying medications: differentiating “clinical inertia” from appropriate care. J Gen Intern Med 2007 Dec; 22(12): 1648–55PubMedCrossRef Safford MM, Shewchuk R, Qu H, et al. Reasons for not intensifying medications: differentiating “clinical inertia” from appropriate care. J Gen Intern Med 2007 Dec; 22(12): 1648–55PubMedCrossRef
20.
go back to reference Mancia G, De Backer G, Dominiczak A, et al.; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [published erratum appears in J Hypertens dy2007 Aug; 25 (8): 1749]. J Hypertens 2007 Jun; 25(6): 1105–87PubMedCrossRef Mancia G, De Backer G, Dominiczak A, et al.; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [published erratum appears in J Hypertens dy2007 Aug; 25 (8): 1749]. J Hypertens 2007 Jun; 25(6): 1105–87PubMedCrossRef
21.
go back to reference O’Brien E, Asmar R, Beilin L, et al., European Society of Hypertension Working Group on BP Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home BP measurement. J Hypertens 2003 May; 21(5): 821–48PubMedCrossRef O’Brien E, Asmar R, Beilin L, et al., European Society of Hypertension Working Group on BP Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home BP measurement. J Hypertens 2003 May; 21(5): 821–48PubMedCrossRef
22.
go back to reference Maiques Galán A, Villar Alvarez F, Brotons Cuixart C, et al.; Grupo de Prevención Cardiovascular del PAPPS. Preventive cardiovascular recommendations. Aten Primaria 2007 Nov; 39Suppl. 3: 15–26PubMed Maiques Galán A, Villar Alvarez F, Brotons Cuixart C, et al.; Grupo de Prevención Cardiovascular del PAPPS. Preventive cardiovascular recommendations. Aten Primaria 2007 Nov; 39Suppl. 3: 15–26PubMed
23.
go back to reference Gil-Guillén V, Orozco-Beltrán D, Pérez RP, et al. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press 2010 Feb; 19(1): 3–10PubMedCrossRef Gil-Guillén V, Orozco-Beltrán D, Pérez RP, et al. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press 2010 Feb; 19(1): 3–10PubMedCrossRef
24.
go back to reference Lüders S, Schrader J, Schmieder RE, et al. Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial. Eur J Cardiovasc Prev Rehabil 2010 Jun; 17(3): 271–9PubMed Lüders S, Schrader J, Schmieder RE, et al. Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial. Eur J Cardiovasc Prev Rehabil 2010 Jun; 17(3): 271–9PubMed
25.
go back to reference Cushman WC, Ford CE, Cutler JA, et al., ALLHAT Collaborative Research Group. Success and predictors of BP control in diverse North American settings: the anti-hypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002 Nov–Dec; 4(6): 393–404CrossRef Cushman WC, Ford CE, Cutler JA, et al., ALLHAT Collaborative Research Group. Success and predictors of BP control in diverse North American settings: the anti-hypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002 Nov–Dec; 4(6): 393–404CrossRef
26.
go back to reference Mancia G, Laurent S, Agabiti-Rosei E, et al., European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009 Nov; 27(11): 2121–58PubMedCrossRef Mancia G, Laurent S, Agabiti-Rosei E, et al., European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009 Nov; 27(11): 2121–58PubMedCrossRef
27.
go back to reference Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal BP on the risk of cardiovascular disease. N Engl J Med 2001 Nov 1; 345(18): 1291–7PubMedCrossRef Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal BP on the risk of cardiovascular disease. N Engl J Med 2001 Nov 1; 345(18): 1291–7PubMedCrossRef
28.
go back to reference Lewington S, Clarke R, Qizilbash N, et al., Prospective Studies Collaboration. Age-specific relevance of usual BP to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies [published erratum appears in Lancet 2003 Mar 22; 361 (9362): 1060]. Lancet 2002 Dec 14; 360(9349): 1903–13PubMedCrossRef Lewington S, Clarke R, Qizilbash N, et al., Prospective Studies Collaboration. Age-specific relevance of usual BP to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies [published erratum appears in Lancet 2003 Mar 22; 361 (9362): 1060]. Lancet 2002 Dec 14; 360(9349): 1903–13PubMedCrossRef
29.
go back to reference Arguedas JA, Perez MI, Wright JM. Treatment BP targets for hypertension. Cochrane Database Syst Rev 2009 Jul 8; (3): CD004349 Arguedas JA, Perez MI, Wright JM. Treatment BP targets for hypertension. Cochrane Database Syst Rev 2009 Jul 8; (3): CD004349
30.
go back to reference Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998 May 21; 338(21): 1516–20PubMedCrossRef Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998 May 21; 338(21): 1516–20PubMedCrossRef
31.
go back to reference Parchman ML, Pugh JA, Romero RL, et al. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med 2007 May–Jun; 5(3): 196–201PubMedCrossRef Parchman ML, Pugh JA, Romero RL, et al. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med 2007 May–Jun; 5(3): 196–201PubMedCrossRef
32.
go back to reference Llisterri Caro JL, Rodríguez Roca GC, Alonso Moreno FJ, et al.; Grupo de Trabajo de Hipertension Arterial de la Sociedad Española de Medicina Rural y Generalista (Grupo HTA/SEMERGEN); Investigadores del Estudio PRESCAP 2002. BP control in Spanish hypertensive patients in Primary Health Care Centres. PRESCAP 2002 Study [in Spanish]. Med Clin (Barc) 2004 Feb 14; 122(5): 165–71CrossRef Llisterri Caro JL, Rodríguez Roca GC, Alonso Moreno FJ, et al.; Grupo de Trabajo de Hipertension Arterial de la Sociedad Española de Medicina Rural y Generalista (Grupo HTA/SEMERGEN); Investigadores del Estudio PRESCAP 2002. BP control in Spanish hypertensive patients in Primary Health Care Centres. PRESCAP 2002 Study [in Spanish]. Med Clin (Barc) 2004 Feb 14; 122(5): 165–71CrossRef
33.
go back to reference Rodríguez Roca GC, Artigao Ródenas LM, Llisterri Caro JL, et al. Control of hypertension in elderly patients receiving primary care in Spain. Rev Esp Cardiol 2005 Apr; 58(4): 359–66PubMedCrossRef Rodríguez Roca GC, Artigao Ródenas LM, Llisterri Caro JL, et al. Control of hypertension in elderly patients receiving primary care in Spain. Rev Esp Cardiol 2005 Apr; 58(4): 359–66PubMedCrossRef
34.
go back to reference Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines?. A framework for improvement. JAMA 1999 Oct 20; 282(15): 1458–65PubMedCrossRef Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines?. A framework for improvement. JAMA 1999 Oct 20; 282(15): 1458–65PubMedCrossRef
35.
go back to reference Jamerson K, Weber MA, Bakris GL, et al., ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008 Dec 4; 359(23): 2417–28PubMedCrossRef Jamerson K, Weber MA, Bakris GL, et al., ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008 Dec 4; 359(23): 2417–28PubMedCrossRef
36.
go back to reference Glynn LG, Murphy AW, Smith SM, et al. Interventions used to improve control of BP in patients with hypertension. Cochrane Database Syst Rev 2010 Mar 17; (3): CD005182 Glynn LG, Murphy AW, Smith SM, et al. Interventions used to improve control of BP in patients with hypertension. Cochrane Database Syst Rev 2010 Mar 17; (3): CD005182
37.
go back to reference Gorostidi M, Sobrino J, Segura J, et al., Spanish Society of Hypertension ABPM Registry Investigators. Ambulatory BP monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens 2007 May; 25(5): 977–84PubMedCrossRef Gorostidi M, Sobrino J, Segura J, et al., Spanish Society of Hypertension ABPM Registry Investigators. Ambulatory BP monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens 2007 May; 25(5): 977–84PubMedCrossRef
38.
go back to reference Kerr EA, Zikmund-Fisher BJ, Klamerus ML, et al. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med 2008 May 20; 148(10): 717–27PubMed Kerr EA, Zikmund-Fisher BJ, Klamerus ML, et al. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med 2008 May 20; 148(10): 717–27PubMed
39.
go back to reference Howes F, Hansen E, Williams D, et al. Barriers to diagnosing and managing hypertension-a qualitative study in Australian general practice. Aust Fam Physician 2010 Jun–Jul; 39(6): 511–6PubMed Howes F, Hansen E, Williams D, et al. Barriers to diagnosing and managing hypertension-a qualitative study in Australian general practice. Aust Fam Physician 2010 Jun–Jul; 39(6): 511–6PubMed
Metadata
Title
Is There a Predictive Profile for Clinical Inertia in Hypertensive Patients?
An Observational, Cross-Sectional, Multicentre Study
Authors
Prof. Dr Vicente Gil-Guillén
Domingo Orozco-Beltrán
Emilio Márquez-Contreras
Ramón Durazo-Arvizu
Richard Cooper
Salvador Pita-Fernández
Diego González-Segura
Concepción Carratalá-Munuera
José Luis Martín de Pablo
Vicente Pallarés
Salvador Pertusa-Martínez
Antonio Fernández
Josep Redón
Publication date
01-12-2011
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 12/2011
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/11596640-000000000-00000

Other articles of this Issue 12/2011

Drugs & Aging 12/2011 Go to the issue

Acknowledgments

Acknowledgement

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.